FLWPF (The Flowr) Notes Receivable: $0.00 Mil (As of Sep. 2022)


What is The Flowr Notes Receivable?

The Flowr FLWPF -90.00% Notes Receivable is $0.00 Mil as of Sep. 2022.

The Flowr's Notes Receivable for the quarter that ended in Sep. 2022 was $0.00 Mil.

The Flowr Notes Receivable Historical Data

* Premium members only.

The historical data trend for The Flowr's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Flowr Notes Receivable Chart

The Flowr Annual Data
Trend Jun17 Jun18 Dec19 Dec20 Dec21
Notes Receivable
0.00 0.00 0.00 0.00 0.00

The Flowr Quarterly Data
Sep17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

The Flowr Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of $0.00 Mil mean?
The Flowr (FLWPF) has a Notes Receivable of $0.00 Mil as of Sep. 2022. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on The Flowr and its competitors.
Is The Flowr's Notes Receivable too high?
The Flowr's current Notes Receivable is $0.00 Mil.
How does The Flowr's Notes Receivable compare to ZTS and CTLT?
The Flowr's Notes Receivable of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Drug Manufacturers company?
A good Notes Receivable depends on the Drug Manufacturers industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on The Flowr and its competitors. The Flowr's current Notes Receivable is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Flowr stock overvalued right now?
The Flowr (FLWPF) has a current Notes Receivable of $0.00 Mil. The current Notes Receivable is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For The Flowr (FLWPF), the current Notes Receivable is $0.00 Mil as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The Flowr Business Description

Address 365 Bay Street, Suite 800, Toronto, ON, CAN, M5H 2V1
The Flowr Corp is a Toronto-headquartered cannabis company with operations in Canada and Europe. Its Canadian operating campus, located in Kelowna, BC, includes a purpose-built, GMP-designed indoor cultivation facility; an outdoor and greenhouse cultivation site; and a R&D facility that is awaiting licensing from Health Canada. From this campus, Flowr produces recreational and medicinal products. Internationally, it intends to service the global medical cannabis market through its subsidiary Holigen, which has a license for cannabis cultivation in Portugal and operates GMP licensed facilities in Portugal.